We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration are strengthening cooperation on medical device regulation, to support faster access to safe, innovative technologies for patien…
New partnership accelerates NHS patients' access to new medicines and will see UK benefit from greater life sciences industry investment
As with any medicine, the MHRA will keep the safety and effectiveness of sevabertinib under close review.
Emerging technologies like AI and advanced therapies are transforming healthcare, and through international collaboration with partners such as Singapore’s HSA, the MHRA is accelerating patient access to innovative treatment…
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants.
Medicines and Healthcare products Regulatory Agency (MHRA) takes decisive action to phase out animal testing by helping developers to make greater use of New Approach Methodologies (NAMs).
As a precautionary measure, Mölnlycke Health Care is recalling three batches of Hibiwash, an antimicrobial wash, due to microbial contamination at the manufacturing facility.
Information on the other regulatory bodies responsible for e-cigarette and vape products.
New pathway set to synchronise licensing and value assessment decisions
Expanding medicine reclassification could improve access to treatments, empower self-care, and reduce pressure on NHS services.
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.
New analysis shows Clinical Practice Research Datalink has supported groundbreaking medical research across 29 countries with close to 3,800 published studies
The MHRA has advised pharmacy and healthcare professionals to return all remaining stock to their suppliers
UK Space Agency, MHRA, RIO and CAA set out support for in-orbit manufacturing of pharmaceuticals
Patients could benefit from more effective, higher quality and longer lasting medicines as the UK sets out a clearer route to bring drugs manufactured in space safely to market.
A man who unlawfully supplied Class B and Class C controlled drugs and a range of unauthorised medicines has been sentenced at Stoke-on-Trent Crown Court following an investigation by the MHRA’s Criminal Enforcement Unit.
The MHRA invited the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK.
Officers from the MHRA's Criminal Enforcement Unit (CEU) have raided two separate premises as part of an ongoing investigation into an organised criminal network involved in the manufacture and sale of unlicensed weight …
Fake medicines are illegally produced products that may contain incorrect ingredients, no active ingredients, or harmful substances.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).